European Food Safety Authority Declares Saccharin Safe: Benefits and Implications for Food Safety
Saccharin is a sweetener used for over 100 years, popular as a sugar substitute in the 1960s and 1970s. Initial studies linked it to bladder cancer in rats, but researchers now believe these findings do not apply to humans. The European Food Safety Authority (EFSA) states that current consumption of saccharin is below the updated recommended daily amount, indicating no safety issues.
Dietitian Juan Revenga explained that EFSA’s safety guidelines are based on general consumption patterns. He noted that manufacturers do not include more than the acceptable daily intake (ADI) in products. European authorities adopt a precautionary principle, setting additional restrictions to prevent exceeding the ADI.
Revenga highlighted that a saccharin tablet or sweetener sachet contains bulking agents along with saccharin. This means the amount of saccharin in each tablet is small compared to the bulking agent.
While the EFSA considers saccharin safe, research continues on its effects. A 2022 study suggested that saccharin and similar sweeteners might change the gut microbiome and impact glucose tolerance. The World Health Organization (WHO) has expressed concerns about the long-term use of sweeteners like saccharin for weight control, linking them to higher risks of type 2 diabetes.
How does saccharin compare to other artificial sweeteners in terms of safety and health risks?
Interview with Dietitian Juan Revenga on the Safety and Impact of Saccharin
News Directory 3: Thank you for joining us today, Juan. Saccharin has been a popular sweetener for over a century, with a controversial history initially linked to bladder cancer in rats. Can you explain what led to the shift in perception regarding its safety for human consumption?
Juan Revenga: Thank you for having me. The initial studies that raised concerns were based on animal research, specifically in rats. Over time, more extensive studies and comprehensive analyses carried out by organizations like the European Food Safety Authority (EFSA) have concluded that these findings are not applicable to humans. Current research suggests that the doses of saccharin we consume are generally safe and well below the updated recommended daily intake.
News Directory 3: What factors did the EFSA consider when establishing safety guidelines for saccharin?
Juan Revenga: The EFSA’s safety guidelines are based on general consumption patterns, which means they take into account the average intake levels across populations. Manufacturers of sweeteners are careful to ensure that products do not contain more than the acceptable daily intake (ADI) of saccharin. Additionally, European authorities apply a precautionary principle, which imposes further restrictions to prevent consumers from exceeding the ADI.
News Directory 3: You mentioned that saccharin tablets and sweetener sachets contain bulking agents. How does that affect the actual amount of saccharin consumed?
Juan Revenga: Exactly. When you see a saccharin tablet or a sachet of sweetener, the amount of saccharin itself is relatively small compared to the bulking agents used. These bulking agents are necessary to provide volume and a suitable texture for the product, which means that the portion of saccharin you ingest in a normal serving size is minimal.
News Directory 3: Despite the current safety stance, there seems to be ongoing research regarding the long-term effects of saccharin. Can you tell us more about this?
Juan Revenga: Certainly. While the EFSA considers saccharin safe based on current evidence, research continues to investigate its long-term effects. For instance, a 2022 study suggested that saccharin and similar sweeteners might alter the gut microbiome and affect glucose tolerance. Additionally, the World Health Organization (WHO) has voiced concerns about the long-term use of these sweeteners for weight management, noting potential links to an increased risk of type 2 diabetes.
News Directory 3: Interestingly, the International Agency for Research on Cancer (IARC) provided classifications regarding saccharin and aspartame. Can you elaborate on that?
Juan Revenga: Yes, in 1998 the IARC classified saccharin as “not classifiable” for human carcinogenicity, which means they don’t have enough evidence to affirm its carcinogenic potential in humans. In contrast, in 2022, aspartame received a classification as possibly carcinogenic, based on limited evidence of harm at typical doses. These classifications highlight the ongoing need for thorough evaluations of food additives and their safety.
News Directory 3: How does the reevaluation of saccharin fit into the broader context of food additives in the EU?
Juan Revenga: The reevaluation of saccharin is part of a broader review of food additives mandated by EU regulation since January 20, 2009. This regulation emphasizes the need for continual reassessment of food substances to ensure consumer safety and adapt to new scientific findings as they arise.
News Directory 3: Thank you, Juan, for your insights into the safety and implications of saccharin as a sweetener. It’s clear that this topic remains important as we learn more about food additives and their effects on health.
Juan Revenga: Thank you for having me. It’s crucial for consumers to be informed about what they eat, and ongoing research will help us better understand these substances.
The International Agency for Research on Cancer (IARC) classified saccharin as “not classifiable” for human carcinogenicity in 1998. It classified another sweetener, aspartame, as possibly carcinogenic in 2022, indicating limited evidence of harm at typical doses.
This reevaluation of saccharin fits into a broader review of food additives by the EFSA, required by EU regulation since January 20, 2009.